All News

Investigators observed improvements in inflammation of the cornea and ocular itching among patients receiving Verkazia in both trials.

Ribociclib was found to prolong overall survival and improve post-progression outcomes in patients with HR-positive/HER2−negative advanced breast cancer, particularly among younger patients with a significant unmet need.

Results from the LOTIS-2 and LOTIS-3 trials show durable responses and a manageable toxicity profile among patients with both diffuse large B-cell lymphoma and mantle cell lymphoma treated with loncastuximab tesirine-lpyl (Zynlonta).

Further, the ISCs reside in a series of regularly folded valleys of the gut, which the researchers call crypts.

Individuals with diabetes, and other related underlying health conditions, are being hospitalized 6 times more often and are 12 times more likely to die of COVID-19 than those without diabetes.

The researchers noted that during high-risk pregnancies, special monitoring and care throughout the pregnancy is mandatory.

Community pharmacy teams can help reduce hospitalizations through the provision of medication reconciliation, which adjudicates discrepancies such as therapeutic omissions, duplications, dosing errors, drug interactions, and unintentional therapeutic changes.

Investigators found that a single initial dose may be sufficient for patients with prior infection.

The research team discovered that community pharmacists, as a skilled clinical workforce, could positively contribute to the future of COVID-19 vaccination programs by continuing to be active in COVID-19 vaccination campaigns.

New drug products from Glenmark Pharmaceuticals and Cipla Limited are therapeutic equivalents to Sunovion Pharmaceuticals’ Brovana Inhalation Solution, 15 mcg/2 mL.

The investigators said that although pneumococcal vaccines were known to reduce severe cases of childhood pneumonia, no studies from Asia had measured their efficacy until now.

A study comparing once-monthly injectable galcanezumab-gnlm with rimegepant has been planned to support the assessment of potential treatments to prevent migraines.

According to the authors of the KEYNOTE-826 trial results, this is the first anti-programmed death receptor-1 (PD-1)/PD-L1 therapy to demonstrate improvements in OS and PFS that were clinically meaningful and statistically significant regardless of PD-L1 status.

Investigators identified 2 subgroups at risk of developing bacterial biofilms: those who have taken a significant amount of medications over their lifetimes and those who have undergone organ transplants.

Patients who received non-opioid prescriptions were more likely to report having no pain in the first week after surgery than those who received opioids and both groups reported equal levels of satisfaction.

Primary results from the randomized portion of the INVICTUS study had previously shown that ripretinib was able to significantly improve progression-free survival with a clinically meaningful overall survival benefit in patients with advanced gastrointestinal stromal tumor.

The demand for drug treatments in Europe and North American has increased in recent years, as awareness of the bleeding disorder rises.

From Tuesday, June 22 to Saturday, June 26, customers getting a COVID-19 vaccination at Walgreens pharmacies will receive $25 in Walgreens cash rewards for in-store purchases.

The FDA also approved dabigatran etexilate oral pellets for the prevention of recurrent clots in patients aged 3 months to less than 12 years of age who have completed treatment for their first venous thromboembolism.

Jordan Tishler, MD, president of the Association of Cannabis Specialists and faculty at Harvard Medical School, discusses his outlook on the future of both care for patients with PTSD and acknowledgement of the role of cannabis in its treatment.

Researchers noted decreases in control of blood pressure as well as non¬–high-density lipoprotein cholesterol, both of which are risk factors for diabetes.

Suzanne Soliman, PharmD, BCMAS, and Sally Arif, PharmD, BCPS, BCCP, discuss how the COVID-19 pandemic has impacted women in the pharmacy field.

A research team from the university wanted to further investigate whether patients with or without insurance were paying more because of rebates to insurers.

In the ZUMA-5 cohort, 94% of patients achieved a response compared to 50% of patients in the control cohort with an odds ratio of 16.2.

Eligible participants at baseline had more than 1 year of continuous insurance coverage, allowing gaps less than 90 days, and were free of CVD 1 year prior to OSA diagnosis.

Investigators have found bNAbs for HIV, hepatitis C, and influenza, among others.

Xembify (immune globulin subcutaneous human–klhw) is a 20% immune globulin indicated for treatment of primary humoral immunodeficiency disease in patients 2 years of age and older.

Previous trials in non-hospitalized patients with COVID-19 suggested casirivimab and imdevimab reduced viral levels, shortened the time to resolution of symptoms and significantly reduced the risk of hospitalization or death.